CN Patent

CN111909130A — 作为突变型异柠檬酸脱氢酶抑制剂的吡啶-2(1h)-酮喹啉酮衍生物

Assigned to Forma Therapeutics Inc · Expires 2020-11-10 · 6y expired

What this patent protects

本发明涉及可用于治疗细胞增殖病症和癌症的具有新生变形活性的突变型异柠檬酸脱氢酶(mt‑IDH)蛋白的抑制剂，其具有式：(I)，其中A、U、W1、W2、W3、R1‑R6及R9如本文所述。

USPTO Abstract

本发明涉及可用于治疗细胞增殖病症和癌症的具有新生变形活性的突变型异柠檬酸脱氢酶(mt‑IDH)蛋白的抑制剂，其具有式：(I)，其中A、U、W1、W2、W3、R1‑R6及R9如本文所述。

Drugs covered by this patent

Patent Metadata

Patent number
CN111909130A
Jurisdiction
CN
Classification
—
Expires
2020-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Forma Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.